Steven A. Kriegsman, Director at RXI PHARMACEUTICALS CORP (RXII), sold 5,100 shares at $4.74 ($24K) on 2009-05-01, disclosed to the SEC on 2009-05-05.
Scheduled sale ($24k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.74 | 2,800 | $13K | 54.3% |
| 2 | $4.86 | 2,300 | $11K | 45.7% |
| Total | $4.79 avg | 5,100 | $24K | 100% |
| Filing → |
| CYTR | BUY | 2012-02-24 | $51K | — | Filing → |
| RXII | SELL | 2009-08-20 | $28K | — | Filing → |
| RXII | SELL | 2009-07-06 | $13K | — | Filing → |